M00001 |
1001 | 92.8 |
5180 | 56.3 |
637 | 95.9 |
153 | 96.2 |
182 | 97.3 |
29 | 42.0 |
5060 | 57.7 |
120 | 27.3 |
Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate |
M00002 |
1039 | 96.3 |
8176 | 88.8 |
643 | 96.8 |
154 | 96.9 |
183 | 97.9 |
59 | 85.5 |
7858 | 89.6 |
318 | 72.4 |
Glycolysis, core module involving three-carbon compounds |
M00003 |
972 | 90.1 |
5464 | 59.4 |
629 | 94.7 |
150 | 94.3 |
171 | 91.4 |
22 | 31.9 |
5294 | 60.4 |
170 | 38.7 |
Gluconeogenesis, oxaloacetate => fructose-6P |
M00004 |
953 | 88.3 |
4603 | 50.0 |
616 | 92.8 |
153 | 96.2 |
161 | 86.1 |
23 | 33.3 |
4603 | 52.5 |
0 | 0.0 |
Pentose phosphate pathway (Pentose phosphate cycle) |
M00005 |
1062 | 98.4 |
8906 | 96.7 |
660 | 99.4 |
158 | 99.4 |
179 | 95.7 |
65 | 94.2 |
8483 | 96.8 |
423 | 96.4 |
PRPP biosynthesis, ribose 5P => PRPP |
M00006 |
1031 | 95.6 |
5191 | 56.4 |
645 | 97.1 |
155 | 97.5 |
180 | 96.3 |
51 | 73.9 |
5179 | 59.1 |
12 | 2.7 |
Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P |
M00007 |
988 | 91.6 |
7338 | 79.7 |
633 | 95.3 |
157 | 98.7 |
166 | 88.8 |
32 | 46.4 |
7293 | 83.2 |
45 | 10.3 |
Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P |
M00008 |
0 | 0.0 |
2397 | 26.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2397 | 27.3 |
0 | 0.0 |
Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate |
M00009 |
757 | 70.2 |
5947 | 64.6 |
525 | 79.1 |
80 | 50.3 |
148 | 79.1 |
4 | 5.8 |
5831 | 66.5 |
116 | 26.4 |
Citrate cycle (TCA cycle, Krebs cycle) |
M00010 |
1002 | 92.9 |
7020 | 76.3 |
624 | 94.0 |
152 | 95.6 |
174 | 93.0 |
52 | 75.4 |
6830 | 77.9 |
190 | 43.3 |
Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate |
M00011 |
797 | 73.9 |
6289 | 68.3 |
555 | 83.6 |
84 | 52.8 |
153 | 81.8 |
5 | 7.2 |
6109 | 69.7 |
180 | 41.0 |
Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate |
M00012 |
325 | 30.1 |
3370 | 36.6 |
4 | 0.6 |
142 | 89.3 |
171 | 91.4 |
8 | 11.6 |
3329 | 38.0 |
41 | 9.3 |
Glyoxylate cycle |
M00013 |
227 | 21.0 |
0 | 0.0 |
136 | 20.5 |
1 | 0.6 |
89 | 47.6 |
1 | 1.4 |
0 | 0.0 |
0 | 0.0 |
Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA |
M00014 |
564 | 52.3 |
0 | 0.0 |
564 | 84.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glucuronate pathway (uronate pathway) |
M00015 |
1001 | 92.8 |
6928 | 75.3 |
644 | 97.0 |
157 | 98.7 |
174 | 93.0 |
26 | 37.7 |
6825 | 77.8 |
103 | 23.5 |
Proline biosynthesis, glutamate => proline |
M00016 |
0 | 0.0 |
4522 | 49.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4520 | 51.6 |
2 | 0.5 |
Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine |
M00017 |
124 | 11.5 |
2785 | 30.3 |
0 | 0.0 |
0 | 0.0 |
123 | 65.8 |
1 | 1.4 |
2785 | 31.8 |
0 | 0.0 |
Methionine biosynthesis, aspartate => homoserine => methionine |
M00018 |
320 | 29.7 |
6952 | 75.5 |
0 | 0.0 |
153 | 96.2 |
163 | 87.2 |
4 | 5.8 |
6693 | 76.3 |
259 | 59.0 |
Threonine biosynthesis, aspartate => homoserine => threonine |
M00019 |
326 | 30.2 |
6956 | 75.6 |
0 | 0.0 |
153 | 96.2 |
173 | 92.5 |
0 | 0.0 |
6670 | 76.1 |
286 | 65.1 |
Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine |
M00020 |
907 | 84.1 |
4900 | 53.2 |
612 | 92.2 |
156 | 98.1 |
130 | 69.5 |
9 | 13.0 |
4881 | 55.7 |
19 | 4.3 |
Serine biosynthesis, glycerate-3P => serine |
M00021 |
181 | 16.8 |
6389 | 69.4 |
0 | 0.0 |
159 | 100.0 |
1 | 0.5 |
21 | 30.4 |
6236 | 71.1 |
153 | 34.9 |
Cysteine biosynthesis, serine => cysteine |
M00022 |
329 | 30.5 |
4469 | 48.5 |
0 | 0.0 |
147 | 92.5 |
171 | 91.4 |
11 | 15.9 |
4459 | 50.9 |
10 | 2.3 |
Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate |
M00023 |
313 | 29.0 |
5777 | 62.8 |
0 | 0.0 |
149 | 93.7 |
164 | 87.7 |
0 | 0.0 |
5456 | 62.2 |
321 | 73.1 |
Tryptophan biosynthesis, chorismate => tryptophan |
M00024 |
123 | 11.4 |
2087 | 22.7 |
0 | 0.0 |
1 | 0.6 |
122 | 65.2 |
0 | 0.0 |
2087 | 23.8 |
0 | 0.0 |
Phenylalanine biosynthesis, chorismate => phenylpyruvate => phenylalanine |
M00025 |
157 | 14.6 |
1458 | 15.8 |
0 | 0.0 |
0 | 0.0 |
157 | 84.0 |
0 | 0.0 |
1458 | 16.6 |
0 | 0.0 |
Tyrosine biosynthesis, chorismate => HPP => tyrosine |
M00026 |
299 | 27.7 |
4758 | 51.7 |
2 | 0.3 |
141 | 88.7 |
153 | 81.8 |
3 | 4.3 |
4684 | 53.4 |
74 | 16.9 |
Histidine biosynthesis, PRPP => histidine |
M00027 |
944 | 87.5 |
929 | 10.1 |
632 | 95.2 |
144 | 90.6 |
168 | 89.8 |
0 | 0.0 |
914 | 10.4 |
15 | 3.4 |
GABA (gamma-Aminobutyrate) shunt |
M00028 |
282 | 26.1 |
5996 | 65.1 |
0 | 0.0 |
156 | 98.1 |
123 | 65.8 |
3 | 4.3 |
5861 | 66.9 |
135 | 30.8 |
Ornithine biosynthesis, glutamate => ornithine |
M00029 |
381 | 35.3 |
0 | 0.0 |
376 | 56.6 |
0 | 0.0 |
0 | 0.0 |
5 | 7.2 |
0 | 0.0 |
0 | 0.0 |
Urea cycle |
M00030 |
150 | 13.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
150 | 80.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine |
M00031 |
0 | 0.0 |
159 | 1.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
59 | 0.7 |
100 | 22.8 |
Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine |
M00032 |
427 | 39.6 |
0 | 0.0 |
426 | 64.2 |
0 | 0.0 |
0 | 0.0 |
1 | 1.4 |
0 | 0.0 |
0 | 0.0 |
Lysine degradation, lysine => saccharopine => acetoacetyl-CoA |
M00033 |
0 | 0.0 |
1048 | 11.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1033 | 11.8 |
15 | 3.4 |
Ectoine biosynthesis, aspartate => ectoine |
M00034 |
667 | 61.8 |
808 | 8.8 |
419 | 63.1 |
143 | 89.9 |
92 | 49.2 |
13 | 18.8 |
808 | 9.2 |
0 | 0.0 |
Methionine salvage pathway |
M00035 |
766 | 71.0 |
1127 | 12.2 |
644 | 97.0 |
2 | 1.3 |
105 | 56.1 |
15 | 21.7 |
1103 | 12.6 |
24 | 5.5 |
Methionine degradation |
M00036 |
787 | 72.9 |
1045 | 11.4 |
534 | 80.4 |
140 | 88.1 |
105 | 56.1 |
8 | 11.6 |
1045 | 11.9 |
0 | 0.0 |
Leucine degradation, leucine => acetoacetate + acetyl-CoA |
M00037 |
357 | 33.1 |
0 | 0.0 |
357 | 53.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Melatonin biosynthesis, animals, tryptophan => serotonin => melatonin |
M00038 |
428 | 39.7 |
58 | 0.6 |
425 | 64.0 |
0 | 0.0 |
3 | 1.6 |
0 | 0.0 |
58 | 0.7 |
0 | 0.0 |
Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate |
M00039 |
137 | 12.7 |
0 | 0.0 |
0 | 0.0 |
137 | 86.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Monolignol biosynthesis, phenylalanine/tyrosine => monolignol |
M00040 |
157 | 14.6 |
523 | 5.7 |
0 | 0.0 |
155 | 97.5 |
0 | 0.0 |
2 | 2.9 |
523 | 6.0 |
0 | 0.0 |
Tyrosine biosynthesis, chorismate => arogenate => tyrosine |
M00042 |
353 | 32.7 |
0 | 0.0 |
353 | 53.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline |
M00043 |
401 | 37.2 |
1 | 0.0 |
401 | 60.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine |
M00044 |
826 | 76.6 |
897 | 9.7 |
610 | 91.9 |
143 | 89.9 |
62 | 33.2 |
11 | 15.9 |
897 | 10.2 |
0 | 0.0 |
Tyrosine degradation, tyrosine => homogentisate |
M00045 |
466 | 43.2 |
3307 | 35.9 |
459 | 69.1 |
0 | 0.0 |
0 | 0.0 |
7 | 10.1 |
3252 | 37.1 |
55 | 12.5 |
Histidine degradation, histidine => N-formiminoglutamate => glutamate |
M00046 |
774 | 71.7 |
979 | 10.6 |
622 | 93.7 |
147 | 92.5 |
0 | 0.0 |
5 | 7.2 |
979 | 11.2 |
0 | 0.0 |
Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate |
M00047 |
395 | 36.6 |
0 | 0.0 |
392 | 59.0 |
0 | 0.0 |
0 | 0.0 |
3 | 4.3 |
0 | 0.0 |
0 | 0.0 |
Creatine pathway |
M00048 |
794 | 73.6 |
7547 | 82.0 |
525 | 79.1 |
137 | 86.2 |
131 | 70.1 |
1 | 1.4 |
7320 | 83.5 |
227 | 51.7 |
De novo purine biosynthesis, PRPP + glutamine => IMP |
M00049 |
1014 | 94.0 |
7634 | 82.9 |
647 | 97.4 |
146 | 91.8 |
168 | 89.8 |
53 | 76.8 |
7235 | 82.5 |
399 | 90.9 |
Adenine ribonucleotide biosynthesis, IMP => ADP,ATP |
M00050 |
1009 | 93.5 |
7222 | 78.4 |
637 | 95.9 |
153 | 96.2 |
165 | 88.2 |
54 | 78.3 |
7222 | 82.4 |
0 | 0.0 |
Guanine ribonucleotide biosynthesis, IMP => GDP,GTP |
M00051 |
735 | 68.1 |
1461 | 15.9 |
593 | 89.3 |
2 | 1.3 |
135 | 72.2 |
5 | 7.2 |
1164 | 13.3 |
297 | 67.7 |
De novo pyrimidine biosynthesis, glutamine (+ PRPP) => UMP |
M00052 |
1037 | 96.1 |
7761 | 84.3 |
651 | 98.0 |
158 | 99.4 |
170 | 90.9 |
58 | 84.1 |
7354 | 83.9 |
407 | 92.7 |
Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP |
M00053 |
1040 | 96.4 |
6459 | 70.2 |
650 | 97.9 |
159 | 100.0 |
179 | 95.7 |
52 | 75.4 |
6346 | 72.4 |
113 | 25.7 |
Deoxyribonucleotide biosynthesis, ADP/GDP/CDP/UDP => dATP/dGTP/dCTP/dUTP |
M00055 |
695 | 64.4 |
0 | 0.0 |
468 | 70.5 |
136 | 85.5 |
89 | 47.6 |
2 | 2.9 |
0 | 0.0 |
0 | 0.0 |
N-glycan precursor biosynthesis |
M00056 |
121 | 11.2 |
0 | 0.0 |
121 | 18.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
O-glycan biosynthesis, mucin type core |
M00057 |
551 | 51.1 |
0 | 0.0 |
550 | 82.8 |
0 | 0.0 |
0 | 0.0 |
1 | 1.4 |
0 | 0.0 |
0 | 0.0 |
Glycosaminoglycan biosynthesis, linkage tetrasaccharide |
M00058 |
547 | 50.7 |
0 | 0.0 |
547 | 82.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosaminoglycan biosynthesis, chondroitin sulfate backbone |
M00059 |
635 | 58.9 |
0 | 0.0 |
635 | 95.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosaminoglycan biosynthesis, heparan sulfate backbone |
M00060 |
0 | 0.0 |
824 | 9.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
824 | 9.4 |
0 | 0.0 |
KDO2-lipid A biosynthesis, Raetz pathway, LpxL-LpxM type |
M00061 |
0 | 0.0 |
1376 | 14.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1376 | 15.7 |
0 | 0.0 |
D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P |
M00063 |
0 | 0.0 |
3549 | 38.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3549 | 40.5 |
0 | 0.0 |
CMP-KDO biosynthesis |
M00064 |
0 | 0.0 |
1967 | 21.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1967 | 22.4 |
0 | 0.0 |
ADP-L-glycero-D-manno-heptose biosynthesis |
M00065 |
303 | 28.1 |
0 | 0.0 |
277 | 41.7 |
13 | 8.2 |
13 | 7.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
GPI-anchor biosynthesis, core oligosaccharide |
M00066 |
406 | 37.6 |
0 | 0.0 |
406 | 61.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Lactosylceramide biosynthesis |
M00067 |
413 | 38.3 |
0 | 0.0 |
412 | 62.0 |
0 | 0.0 |
0 | 0.0 |
1 | 1.4 |
0 | 0.0 |
0 | 0.0 |
Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid |
M00068 |
253 | 23.4 |
0 | 0.0 |
253 | 38.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosphingolipid biosynthesis, globo-series, LacCer => Gb4Cer |
M00069 |
390 | 36.1 |
0 | 0.0 |
390 | 58.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosphingolipid biosynthesis, ganglio series, LacCer => GT3 |
M00070 |
417 | 38.6 |
0 | 0.0 |
417 | 62.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosphingolipid biosynthesis, lacto-series, LacCer => Lc4Cer |
M00071 |
413 | 38.3 |
0 | 0.0 |
413 | 62.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glycosphingolipid biosynthesis, neolacto-series, LacCer => nLc4Cer |
M00072 |
147 | 13.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
147 | 78.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
N-glycosylation by oligosaccharyltransferase |
M00073 |
857 | 79.4 |
0 | 0.0 |
568 | 85.5 |
147 | 92.5 |
140 | 74.9 |
2 | 2.9 |
0 | 0.0 |
0 | 0.0 |
N-glycan precursor trimming |
M00074 |
20 | 1.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
20 | 10.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
N-glycan biosynthesis, high-mannose type |
M00075 |
367 | 34.0 |
0 | 0.0 |
367 | 55.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
N-glycan biosynthesis, complex type |
M00076 |
438 | 40.6 |
0 | 0.0 |
438 | 66.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Dermatan sulfate degradation |
M00077 |
425 | 39.4 |
0 | 0.0 |
425 | 64.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Chondroitin sulfate degradation |
M00078 |
402 | 37.3 |
0 | 0.0 |
402 | 60.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Heparan sulfate degradation |
M00079 |
452 | 41.9 |
0 | 0.0 |
452 | 68.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Keratan sulfate degradation |
M00081 |
217 | 20.1 |
0 | 0.0 |
0 | 0.0 |
144 | 90.6 |
73 | 39.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Pectin degradation |
M00082 |
963 | 89.2 |
6102 | 66.3 |
614 | 92.5 |
156 | 98.1 |
172 | 92.0 |
21 | 30.4 |
6102 | 69.6 |
0 | 0.0 |
Fatty acid biosynthesis, initiation |
M00083 |
992 | 91.9 |
7191 | 78.1 |
630 | 94.9 |
157 | 98.7 |
175 | 93.6 |
30 | 43.5 |
7191 | 82.0 |
0 | 0.0 |
Fatty acid biosynthesis, elongation |
M00085 |
661 | 61.3 |
0 | 0.0 |
646 | 97.3 |
0 | 0.0 |
6 | 3.2 |
9 | 13.0 |
0 | 0.0 |
0 | 0.0 |
Fatty acid elongation in mitochondria |
M00086 |
1076 | 99.7 |
6981 | 75.8 |
663 | 99.8 |
159 | 100.0 |
187 | 100.0 |
67 | 97.1 |
6751 | 77.0 |
230 | 52.4 |
beta-Oxidation, acyl-CoA synthesis |
M00087 |
889 | 82.4 |
2858 | 31.0 |
660 | 99.4 |
155 | 97.5 |
49 | 26.2 |
25 | 36.2 |
2858 | 32.6 |
0 | 0.0 |
beta-Oxidation |
M00088 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone |
M00089 |
922 | 85.4 |
0 | 0.0 |
650 | 97.9 |
158 | 99.4 |
95 | 50.8 |
19 | 27.5 |
0 | 0.0 |
0 | 0.0 |
Triacylglycerol biosynthesis |
M00090 |
607 | 56.3 |
0 | 0.0 |
583 | 87.8 |
0 | 0.0 |
24 | 12.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Phosphatidylcholine (PC) biosynthesis, choline => PC |
M00091 |
626 | 58.0 |
1269 | 13.8 |
425 | 64.0 |
3 | 1.9 |
175 | 93.6 |
23 | 33.3 |
1233 | 14.1 |
36 | 8.2 |
Phosphatidylcholine (PC) biosynthesis, PE => PC |
M00092 |
960 | 89.0 |
0 | 0.0 |
646 | 97.3 |
152 | 95.6 |
114 | 61.0 |
48 | 69.6 |
0 | 0.0 |
0 | 0.0 |
Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE |
M00093 |
168 | 15.6 |
5886 | 63.9 |
0 | 0.0 |
0 | 0.0 |
168 | 89.8 |
0 | 0.0 |
5886 | 67.1 |
0 | 0.0 |
Phosphatidylethanolamine (PE) biosynthesis, PA => PS => PE |
M00094 |
805 | 74.6 |
0 | 0.0 |
647 | 97.4 |
3 | 1.9 |
154 | 82.4 |
1 | 1.4 |
0 | 0.0 |
0 | 0.0 |
Ceramide biosynthesis |
M00095 |
829 | 76.8 |
109 | 1.2 |
556 | 83.7 |
140 | 88.1 |
125 | 66.8 |
8 | 11.6 |
66 | 0.8 |
43 | 9.8 |
C5 isoprenoid biosynthesis, mevalonate pathway |
M00096 |
151 | 14.0 |
2439 | 26.5 |
0 | 0.0 |
146 | 91.8 |
0 | 0.0 |
5 | 7.2 |
2439 | 27.8 |
0 | 0.0 |
C5 isoprenoid biosynthesis, non-mevalonate pathway |
M00097 |
140 | 13.0 |
36 | 0.4 |
0 | 0.0 |
140 | 88.1 |
0 | 0.0 |
0 | 0.0 |
36 | 0.4 |
0 | 0.0 |
beta-Carotene biosynthesis, GGAP => beta-carotene |
M00098 |
978 | 90.6 |
391 | 4.2 |
635 | 95.6 |
159 | 100.0 |
168 | 89.8 |
16 | 23.2 |
391 | 4.5 |
0 | 0.0 |
Acylglycerol degradation |
M00099 |
756 | 70.1 |
0 | 0.0 |
647 | 97.4 |
0 | 0.0 |
108 | 57.8 |
1 | 1.4 |
0 | 0.0 |
0 | 0.0 |
Sphingosine biosynthesis |
M00100 |
939 | 87.0 |
0 | 0.0 |
600 | 90.4 |
151 | 95.0 |
169 | 90.4 |
19 | 27.5 |
0 | 0.0 |
0 | 0.0 |
Sphingosine degradation |
M00101 |
302 | 28.0 |
0 | 0.0 |
302 | 45.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cholesterol biosynthesis, FPP => cholesterol |
M00102 |
127 | 11.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
127 | 67.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ergocalciferol biosynthesis, FPP => ergosterol/ergocalciferol |
M00103 |
345 | 32.0 |
0 | 0.0 |
345 | 52.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cholecalciferol biosynthesis |
M00104 |
34 | 3.2 |
0 | 0.0 |
34 | 5.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate |
M00106 |
154 | 14.3 |
0 | 0.0 |
154 | 23.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate |
M00107 |
379 | 35.1 |
0 | 0.0 |
379 | 57.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Steroid hormone biosynthesis, cholesterol => pregnenolone => progesterone |
M00108 |
31 | 2.9 |
0 | 0.0 |
31 | 4.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone |
M00109 |
289 | 26.8 |
0 | 0.0 |
289 | 43.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone |
M00110 |
390 | 36.1 |
0 | 0.0 |
390 | 58.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone |
M00112 |
158 | 14.6 |
79 | 0.9 |
0 | 0.0 |
154 | 96.9 |
0 | 0.0 |
4 | 5.8 |
79 | 0.9 |
0 | 0.0 |
Tocopherol/tocotorienol biosynthesis, homogentisate + phytyl/geranylgeranyl-PP => tocopherol/tocotorienol |
M00113 |
143 | 13.3 |
0 | 0.0 |
0 | 0.0 |
143 | 89.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Jasmonic acid biosynthesis |
M00114 |
147 | 13.6 |
0 | 0.0 |
0 | 0.0 |
147 | 92.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ascorbate biosynthesis, plants, fructose-6P => ascorbate |
M00115 |
144 | 13.3 |
5226 | 56.8 |
0 | 0.0 |
144 | 90.6 |
0 | 0.0 |
0 | 0.0 |
5226 | 59.6 |
0 | 0.0 |
NAD biosynthesis, aspartate => quinolinate => NAD |
M00116 |
0 | 0.0 |
1247 | 13.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1247 | 14.2 |
0 | 0.0 |
Menaquinone biosynthesis, chorismate (+ polyprenyl-PP) => menaquinol |
M00117 |
0 | 0.0 |
1635 | 17.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1635 | 18.6 |
0 | 0.0 |
Ubiquinone biosynthesis, prokaryotes, chorismate (+ polyprenyl-PP) => ubiquinol |
M00118 |
886 | 82.1 |
3404 | 37.0 |
637 | 95.9 |
155 | 97.5 |
93 | 49.7 |
1 | 1.4 |
3403 | 38.8 |
1 | 0.2 |
Glutathione biosynthesis, glutamate => glutathione |
M00119 |
0 | 0.0 |
2986 | 32.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2986 | 34.1 |
0 | 0.0 |
Pantothenate biosynthesis, valine/L-aspartate => pantothenate |
M00120 |
727 | 67.4 |
7517 | 81.7 |
565 | 85.1 |
108 | 67.9 |
48 | 25.7 |
6 | 8.7 |
7517 | 85.7 |
0 | 0.0 |
Coenzyme A biosynthesis, pantothenate => CoA |
M00121 |
153 | 14.2 |
3332 | 36.2 |
0 | 0.0 |
149 | 93.7 |
0 | 0.0 |
4 | 5.8 |
3332 | 38.0 |
0 | 0.0 |
Heme biosynthesis, plants and bacteria, glutamate => heme |
M00122 |
0 | 0.0 |
2529 | 27.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2529 | 28.8 |
0 | 0.0 |
Cobalamin biosynthesis, cobyrinate a,c-diamide => cobalamin |
M00123 |
276 | 25.6 |
4755 | 51.7 |
0 | 0.0 |
155 | 97.5 |
116 | 62.0 |
5 | 7.2 |
4731 | 54.0 |
24 | 5.5 |
Biotin biosynthesis, pimeloyl-ACP/CoA => biotin |
M00124 |
0 | 0.0 |
1183 | 12.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1183 | 13.5 |
0 | 0.0 |
Pyridoxal-P biosynthesis, erythrose-4P => pyridoxal-P |
M00125 |
146 | 13.5 |
2534 | 27.5 |
0 | 0.0 |
146 | 91.8 |
0 | 0.0 |
0 | 0.0 |
2534 | 28.9 |
0 | 0.0 |
Riboflavin biosynthesis, plants and bacteria, GTP => riboflavin/FMN/FAD |
M00126 |
186 | 17.2 |
3610 | 39.2 |
0 | 0.0 |
124 | 78.0 |
62 | 33.2 |
0 | 0.0 |
3610 | 41.2 |
0 | 0.0 |
Tetrahydrofolate biosynthesis, GTP => THF |
M00127 |
0 | 0.0 |
690 | 7.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
685 | 7.8 |
5 | 1.1 |
Thiamine biosynthesis, prokaryotes, AIR (+ DXP/tyrosine) => TMP/TPP |
M00128 |
758 | 70.3 |
0 | 0.0 |
604 | 91.0 |
0 | 0.0 |
152 | 81.3 |
2 | 2.9 |
0 | 0.0 |
0 | 0.0 |
Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate + polyprenyl-PP => ubiquinol |
M00129 |
230 | 21.3 |
0 | 0.0 |
230 | 34.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ascorbate biosynthesis, animals, glucose-1P => ascorbate |
M00130 |
651 | 60.3 |
0 | 0.0 |
648 | 97.6 |
0 | 0.0 |
0 | 0.0 |
3 | 4.3 |
0 | 0.0 |
0 | 0.0 |
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 |
M00131 |
441 | 40.9 |
0 | 0.0 |
441 | 66.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol |
M00132 |
680 | 63.0 |
0 | 0.0 |
532 | 80.1 |
142 | 89.3 |
0 | 0.0 |
6 | 8.7 |
0 | 0.0 |
0 | 0.0 |
Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate |
M00133 |
0 | 0.0 |
1411 | 15.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1322 | 15.1 |
89 | 20.3 |
Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine |
M00134 |
947 | 87.8 |
813 | 8.8 |
631 | 95.0 |
113 | 71.1 |
175 | 93.6 |
28 | 40.6 |
812 | 9.3 |
1 | 0.2 |
Polyamine biosynthesis, arginine => ornithine => putrescine |
M00135 |
513 | 47.5 |
463 | 5.0 |
513 | 77.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
463 | 5.3 |
0 | 0.0 |
GABA biosynthesis, eukaryotes, putrescine => GABA |
M00136 |
0 | 0.0 |
202 | 2.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
202 | 2.3 |
0 | 0.0 |
GABA biosynthesis, prokaryotes, putrescine => GABA |
M00137 |
144 | 13.3 |
0 | 0.0 |
0 | 0.0 |
144 | 90.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Flavanone biosynthesis, phenylalanine => naringenin |
M00138 |
126 | 11.7 |
0 | 0.0 |
0 | 0.0 |
126 | 79.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Flavonoid biosynthesis, naringenin => pelargonidin |
M00140 |
0 | 0.0 |
3081 | 33.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3026 | 34.5 |
55 | 12.5 |
C1-unit interconversion, prokaryotes |
M00141 |
844 | 78.2 |
0 | 0.0 |
650 | 97.9 |
1 | 0.6 |
177 | 94.7 |
16 | 23.2 |
0 | 0.0 |
0 | 0.0 |
C1-unit interconversion, eukaryotes |
M00142 |
426 | 39.5 |
0 | 0.0 |
362 | 54.5 |
45 | 28.3 |
18 | 9.6 |
1 | 1.4 |
0 | 0.0 |
0 | 0.0 |
NADH:ubiquinone oxidoreductase, mitochondria |
M00143 |
690 | 63.9 |
0 | 0.0 |
508 | 76.5 |
66 | 41.5 |
114 | 61.0 |
2 | 2.9 |
0 | 0.0 |
0 | 0.0 |
NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria |
M00144 |
0 | 0.0 |
4260 | 46.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4260 | 48.6 |
0 | 0.0 |
NADH:quinone oxidoreductase, prokaryotes |
M00145 |
103 | 9.5 |
175 | 1.9 |
0 | 0.0 |
103 | 64.8 |
0 | 0.0 |
0 | 0.0 |
175 | 2.0 |
0 | 0.0 |
NAD(P)H:quinone oxidoreductase, chloroplasts and cyanobacteria |
M00146 |
250 | 23.2 |
0 | 0.0 |
250 | 37.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex |
M00147 |
211 | 19.6 |
0 | 0.0 |
211 | 31.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex |
M00148 |
833 | 77.2 |
0 | 0.0 |
576 | 86.7 |
85 | 53.5 |
167 | 89.3 |
5 | 7.2 |
0 | 0.0 |
0 | 0.0 |
Succinate dehydrogenase (ubiquinone) |
M00149 |
0 | 0.0 |
4413 | 47.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4192 | 47.8 |
221 | 50.3 |
Succinate dehydrogenase, prokaryotes |
M00150 |
0 | 0.0 |
944 | 10.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
944 | 10.8 |
0 | 0.0 |
Fumarate reductase, prokaryotes |
M00151 |
506 | 46.9 |
4425 | 48.1 |
390 | 58.7 |
77 | 48.4 |
27 | 14.4 |
12 | 17.4 |
4425 | 50.5 |
0 | 0.0 |
Cytochrome bc1 complex respiratory unit |
M00152 |
218 | 20.2 |
0 | 0.0 |
209 | 31.5 |
0 | 0.0 |
9 | 4.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cytochrome bc1 complex |
M00153 |
0 | 0.0 |
1612 | 17.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1612 | 18.4 |
0 | 0.0 |
Cytochrome bd ubiquinol oxidase |
M00154 |
210 | 19.5 |
0 | 0.0 |
210 | 31.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cytochrome c oxidase |
M00155 |
0 | 0.0 |
4954 | 53.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4839 | 55.2 |
115 | 26.2 |
Cytochrome c oxidase, prokaryotes |
M00156 |
0 | 0.0 |
2218 | 24.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2218 | 25.3 |
0 | 0.0 |
Cytochrome c oxidase, cbb3-type |
M00157 |
113 | 10.5 |
7722 | 83.9 |
0 | 0.0 |
113 | 71.1 |
0 | 0.0 |
0 | 0.0 |
7722 | 88.1 |
0 | 0.0 |
F-type ATPase, prokaryotes and chloroplasts |
M00158 |
198 | 18.4 |
0 | 0.0 |
180 | 27.1 |
0 | 0.0 |
18 | 9.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
F-type ATPase, eukaryotes |
M00159 |
0 | 0.0 |
583 | 6.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
269 | 3.1 |
314 | 71.5 |
V/A-type ATPase, prokaryotes |
M00160 |
525 | 48.7 |
0 | 0.0 |
525 | 79.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
V-type ATPase, eukaryotes |
M00161 |
117 | 10.8 |
165 | 1.8 |
0 | 0.0 |
116 | 73.0 |
0 | 0.0 |
1 | 1.4 |
165 | 1.9 |
0 | 0.0 |
Photosystem II |
M00162 |
0 | 0.0 |
58 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
58 | 0.7 |
0 | 0.0 |
Cytochrome b6f complex |
M00163 |
115 | 10.7 |
173 | 1.9 |
0 | 0.0 |
114 | 71.7 |
0 | 0.0 |
1 | 1.4 |
173 | 2.0 |
0 | 0.0 |
Photosystem I |
M00165 |
129 | 12.0 |
426 | 4.6 |
0 | 0.0 |
129 | 81.1 |
0 | 0.0 |
0 | 0.0 |
426 | 4.9 |
0 | 0.0 |
Reductive pentose phosphate cycle (Calvin cycle) |
M00168 |
167 | 15.5 |
4008 | 43.5 |
0 | 0.0 |
158 | 99.4 |
0 | 0.0 |
9 | 13.0 |
3786 | 43.2 |
222 | 50.6 |
CAM (Crassulacean acid metabolism), dark |
M00169 |
158 | 14.6 |
1299 | 14.1 |
0 | 0.0 |
153 | 96.2 |
0 | 0.0 |
5 | 7.2 |
1299 | 14.8 |
0 | 0.0 |
CAM (Crassulacean acid metabolism), light |
M00170 |
150 | 13.9 |
0 | 0.0 |
0 | 0.0 |
146 | 91.8 |
0 | 0.0 |
4 | 5.8 |
0 | 0.0 |
0 | 0.0 |
C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type |
M00171 |
144 | 13.3 |
0 | 0.0 |
0 | 0.0 |
144 | 90.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C4-dicarboxylic acid cycle, NAD - malic enzyme type |
M00172 |
150 | 13.9 |
0 | 0.0 |
0 | 0.0 |
150 | 94.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C4-dicarboxylic acid cycle, NADP - malic enzyme type |
M00173 |
0 | 0.0 |
22 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
22 | 0.3 |
0 | 0.0 |
Reductive citrate cycle (Arnon-Buchanan cycle) |
M00174 |
0 | 0.0 |
49 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
49 | 0.6 |
0 | 0.0 |
Methane oxidation, methanotroph, methane => formaldehyde |
M00175 |
0 | 0.0 |
836 | 9.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
765 | 8.7 |
71 | 16.2 |
Nitrogen fixation, nitrogen => ammonia |
M00176 |
311 | 28.8 |
2924 | 31.8 |
0 | 0.0 |
146 | 91.8 |
159 | 85.0 |
6 | 8.7 |
2903 | 33.1 |
21 | 4.8 |
Assimilatory sulfate reduction, sulfate => H2S |
M00307 |
1005 | 93.1 |
8588 | 93.3 |
638 | 96.1 |
158 | 99.4 |
161 | 86.1 |
48 | 69.6 |
8195 | 93.5 |
393 | 89.5 |
Pyruvate oxidation, pyruvate => acetyl-CoA |
M00308 |
0 | 0.0 |
67 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
67 | 15.3 |
Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P |
M00309 |
0 | 0.0 |
52 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
52 | 11.8 |
Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate |
M00338 |
833 | 77.2 |
1310 | 14.2 |
652 | 98.2 |
2 | 1.3 |
166 | 88.8 |
13 | 18.8 |
1291 | 14.7 |
19 | 4.3 |
Cysteine biosynthesis, homocysteine + serine => cysteine |
M00344 |
79 | 7.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
79 | 42.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Formaldehyde assimilation, xylulose monophosphate pathway |
M00345 |
0 | 0.0 |
630 | 6.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
626 | 7.1 |
4 | 0.9 |
Formaldehyde assimilation, ribulose monophosphate pathway |
M00346 |
0 | 0.0 |
54 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
54 | 0.6 |
0 | 0.0 |
Formaldehyde assimilation, serine pathway |
M00356 |
0 | 0.0 |
54 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
54 | 12.3 |
Methanogenesis, methanol => methane |
M00357 |
0 | 0.0 |
81 | 0.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
81 | 18.5 |
Methanogenesis, acetate => methane |
M00358 |
0 | 0.0 |
56 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
55 | 12.5 |
Coenzyme M biosynthesis |
M00363 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
EHEC pathogenicity signature, Shiga toxin |
M00364 |
162 | 15.0 |
4217 | 45.8 |
0 | 0.0 |
156 | 98.1 |
0 | 0.0 |
6 | 8.7 |
3791 | 43.2 |
426 | 97.0 |
C10-C20 isoprenoid biosynthesis, bacteria |
M00365 |
0 | 0.0 |
1504 | 16.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1078 | 12.3 |
426 | 97.0 |
C10-C20 isoprenoid biosynthesis, archaea |
M00366 |
152 | 14.1 |
0 | 0.0 |
0 | 0.0 |
151 | 95.0 |
0 | 0.0 |
1 | 1.4 |
0 | 0.0 |
0 | 0.0 |
C10-C20 isoprenoid biosynthesis, plants |
M00367 |
788 | 73.0 |
0 | 0.0 |
606 | 91.3 |
0 | 0.0 |
167 | 89.3 |
15 | 21.7 |
0 | 0.0 |
0 | 0.0 |
C10-C20 isoprenoid biosynthesis, non-plant eukaryotes |
M00368 |
143 | 13.3 |
0 | 0.0 |
0 | 0.0 |
143 | 89.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ethylene biosynthesis, methionine => ethylene |
M00369 |
11 | 1.0 |
0 | 0.0 |
0 | 0.0 |
11 | 6.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cyanogenic glycoside biosynthesis, tyrosine => dhurrin |
M00370 |
9 | 0.8 |
0 | 0.0 |
0 | 0.0 |
9 | 5.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Glucosinolate biosynthesis, tryptophan => glucobrassicin |
M00371 |
111 | 10.3 |
0 | 0.0 |
0 | 0.0 |
111 | 69.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Castasterone biosynthesis, campesterol => castasterone |
M00372 |
141 | 13.1 |
0 | 0.0 |
0 | 0.0 |
141 | 88.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Abscisic acid biosynthesis, beta-carotene => abscisic acid |
M00373 |
0 | 0.0 |
141 | 1.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
141 | 1.6 |
0 | 0.0 |
Ethylmalonyl pathway |
M00374 |
0 | 0.0 |
12 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
12 | 2.7 |
Dicarboxylate-hydroxybutyrate cycle |
M00375 |
0 | 0.0 |
43 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
43 | 9.8 |
Hydroxypropionate-hydroxybutylate cycle |
M00376 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
3-Hydroxypropionate bi-cycle |
M00377 |
0 | 0.0 |
65 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
65 | 0.7 |
0 | 0.0 |
Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) |
M00378 |
0 | 0.0 |
269 | 2.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
268 | 61.0 |
F420 biosynthesis, archaea |
M00415 |
965 | 89.4 |
0 | 0.0 |
645 | 97.1 |
148 | 93.1 |
134 | 71.7 |
38 | 55.1 |
0 | 0.0 |
0 | 0.0 |
Fatty acid elongation in endoplasmic reticulum |
M00416 |
0 | 0.0 |
506 | 5.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
506 | 5.8 |
0 | 0.0 |
Cytochrome aa3-600 menaquinol oxidase |
M00417 |
0 | 0.0 |
2171 | 23.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2171 | 24.8 |
0 | 0.0 |
Cytochrome o ubiquinol oxidase |
M00418 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
Toluene degradation, anaerobic, toluene => benzoyl-CoA |
M00419 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
Cymene degradation, p-cymene => p-cumate |
M00422 |
0 | 0.0 |
100 | 1.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
99 | 22.6 |
Acetyl-CoA pathway, CO2 => acetyl-CoA |
M00432 |
323 | 29.9 |
7153 | 77.7 |
0 | 0.0 |
151 | 95.0 |
171 | 91.4 |
1 | 1.4 |
6861 | 78.3 |
292 | 66.5 |
Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate |
M00433 |
166 | 15.4 |
42 | 0.5 |
0 | 0.0 |
0 | 0.0 |
166 | 88.8 |
0 | 0.0 |
42 | 0.5 |
0 | 0.0 |
Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate |
M00525 |
0 | 0.0 |
500 | 5.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
500 | 5.7 |
0 | 0.0 |
Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine |
M00526 |
0 | 0.0 |
602 | 6.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
599 | 6.8 |
3 | 0.7 |
Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine |
M00527 |
154 | 14.3 |
1503 | 16.3 |
0 | 0.0 |
153 | 96.2 |
0 | 0.0 |
1 | 1.4 |
1402 | 16.0 |
101 | 23.0 |
Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine |
M00528 |
0 | 0.0 |
42 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
42 | 0.5 |
0 | 0.0 |
Nitrification, ammonia => nitrite |
M00529 |
0 | 0.0 |
313 | 3.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
313 | 3.6 |
0 | 0.0 |
Denitrification, nitrate => nitrogen |
M00530 |
0 | 0.0 |
1442 | 15.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1442 | 16.4 |
0 | 0.0 |
Dissimilatory nitrate reduction, nitrate => ammonia |
M00531 |
256 | 23.7 |
1632 | 17.7 |
0 | 0.0 |
155 | 97.5 |
96 | 51.3 |
5 | 7.2 |
1574 | 18.0 |
58 | 13.2 |
Assimilatory nitrate reduction, nitrate => ammonia |
M00532 |
123 | 11.4 |
0 | 0.0 |
0 | 0.0 |
123 | 77.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Photorespiration |
M00533 |
0 | 0.0 |
566 | 6.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
566 | 6.5 |
0 | 0.0 |
Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate |
M00534 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
Naphthalene degradation, naphthalene => salicylate |
M00535 |
0 | 0.0 |
469 | 5.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
293 | 3.3 |
176 | 40.1 |
Isoleucine biosynthesis, pyruvate => 2-oxobutanoate |
M00537 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
Xylene degradation, xylene => methylbenzoate |
M00538 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
Toluene degradation, toluene => benzoate |
M00539 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate |
M00540 |
0 | 0.0 |
22 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
22 | 0.3 |
0 | 0.0 |
Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA |
M00541 |
0 | 0.0 |
28 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
28 | 0.3 |
0 | 0.0 |
Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA |
M00542 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
EHEC/EPEC pathogenicity signature, T3SS and effectors |
M00543 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate |
M00544 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate |
M00545 |
0 | 0.0 |
378 | 4.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
378 | 4.3 |
0 | 0.0 |
Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA |
M00546 |
192 | 17.8 |
441 | 4.8 |
191 | 28.8 |
0 | 0.0 |
0 | 0.0 |
1 | 1.4 |
441 | 5.0 |
0 | 0.0 |
Purine degradation, xanthine => urea |
M00547 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol |
M00548 |
0 | 0.0 |
183 | 2.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
183 | 2.1 |
0 | 0.0 |
Benzene degradation, benzene => catechol |
M00549 |
1050 | 97.3 |
5071 | 55.1 |
658 | 99.1 |
157 | 98.7 |
178 | 95.2 |
57 | 82.6 |
5057 | 57.7 |
14 | 3.2 |
Nucleotide sugar biosynthesis, glucose => UDP-glucose |
M00550 |
0 | 0.0 |
628 | 6.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
628 | 7.2 |
0 | 0.0 |
Ascorbate degradation, ascorbate => D-xylulose-5P |
M00551 |
0 | 0.0 |
617 | 6.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
617 | 7.0 |
0 | 0.0 |
Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol |
M00552 |
0 | 0.0 |
1091 | 11.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1091 | 12.4 |
0 | 0.0 |
D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P |
M00554 |
744 | 69.0 |
3302 | 35.9 |
586 | 88.3 |
2 | 1.3 |
156 | 83.4 |
0 | 0.0 |
3255 | 37.1 |
47 | 10.7 |
Nucleotide sugar biosynthesis, galactose => UDP-galactose |
M00555 |
620 | 57.5 |
2220 | 24.1 |
467 | 70.3 |
146 | 91.8 |
1 | 0.5 |
6 | 8.7 |
2220 | 25.3 |
0 | 0.0 |
Betaine biosynthesis, choline => betaine |
M00563 |
0 | 0.0 |
39 | 0.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
39 | 8.9 |
Methanogenesis, methylamine/dimethylamine/trimethylamine => methane |
M00564 |
0 | 0.0 |
45 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
45 | 0.5 |
0 | 0.0 |
Helicobacter pylori pathogenicity signature, cagA pathogenicity island |
M00565 |
0 | 0.0 |
629 | 6.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
629 | 7.2 |
0 | 0.0 |
Trehalose biosynthesis, D-glucose 1P => trehalose |
M00567 |
0 | 0.0 |
114 | 1.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
114 | 26.0 |
Methanogenesis, CO2 => methane |
M00568 |
0 | 0.0 |
747 | 8.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
747 | 8.5 |
0 | 0.0 |
Catechol ortho-cleavage, catechol => 3-oxoadipate |
M00569 |
0 | 0.0 |
287 | 3.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
287 | 3.3 |
0 | 0.0 |
Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA |
M00570 |
325 | 30.1 |
6290 | 68.3 |
0 | 0.0 |
153 | 96.2 |
172 | 92.0 |
0 | 0.0 |
6143 | 70.1 |
147 | 33.5 |
Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine |
M00572 |
0 | 0.0 |
1583 | 17.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1583 | 18.1 |
0 | 0.0 |
Pimeloyl-ACP biosynthesis, BioC-BioH pathway, malonyl-ACP => pimeloyl-ACP |
M00573 |
0 | 0.0 |
64 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
64 | 0.7 |
0 | 0.0 |
Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin |
M00574 |
0 | 0.0 |
11 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
11 | 0.1 |
0 | 0.0 |
Pertussis pathogenicity signature, pertussis toxin |
M00575 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
Pertussis pathogenicity signature, T1SS |
M00576 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
ETEC pathogenicity signature, heat-labile and heat-stable enterotoxins |
M00577 |
0 | 0.0 |
313 | 3.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
290 | 3.3 |
23 | 5.2 |
Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin |
M00579 |
0 | 0.0 |
5858 | 63.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5833 | 66.5 |
25 | 5.7 |
Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate |
M00580 |
0 | 0.0 |
719 | 7.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
449 | 5.1 |
270 | 61.5 |
Pentose phosphate pathway, archaea, fructose 6P => ribose 5P |
M00595 |
0 | 0.0 |
516 | 5.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
516 | 5.9 |
0 | 0.0 |
Thiosulfate oxidation by SOX complex, thiosulfate => sulfate |
M00596 |
0 | 0.0 |
140 | 1.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
135 | 1.5 |
5 | 1.1 |
Dissimilatory sulfate reduction, sulfate => H2S |
M00597 |
0 | 0.0 |
194 | 2.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
194 | 2.2 |
0 | 0.0 |
Anoxygenic photosystem II |
M00598 |
0 | 0.0 |
15 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
15 | 0.2 |
0 | 0.0 |
Anoxygenic photosystem I |
M00608 |
0 | 0.0 |
117 | 1.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
117 | 26.7 |
2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate |
M00609 |
0 | 0.0 |
290 | 3.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
290 | 3.3 |
0 | 0.0 |
Cysteine biosynthesis, methionine => cysteine |
M00611 |
118 | 10.9 |
170 | 1.8 |
0 | 0.0 |
118 | 74.2 |
0 | 0.0 |
0 | 0.0 |
170 | 1.9 |
0 | 0.0 |
Oxygenic photosynthesis in plants and cyanobacteria |
M00612 |
0 | 0.0 |
51 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
51 | 0.6 |
0 | 0.0 |
Anoxygenic photosynthesis in purple bacteria |
M00613 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Anoxygenic photosynthesis in green nonsulfur bacteria |
M00614 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
Anoxygenic photosynthesis in green sulfur bacteria |
M00615 |
252 | 23.4 |
1606 | 17.4 |
0 | 0.0 |
155 | 97.5 |
92 | 49.2 |
5 | 7.2 |
1549 | 17.7 |
57 | 13.0 |
Nitrate assimilation |
M00616 |
1 | 0.1 |
1832 | 19.9 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
1832 | 20.9 |
0 | 0.0 |
Sulfate-sulfur assimilation |
M00617 |
0 | 0.0 |
126 | 1.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
126 | 28.7 |
Methanogen |
M00618 |
0 | 0.0 |
51 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
51 | 0.6 |
0 | 0.0 |
Acetogen |
M00620 |
0 | 0.0 |
67 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
67 | 15.3 |
Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate |
M00621 |
971 | 90.0 |
6308 | 68.5 |
619 | 93.2 |
156 | 98.1 |
166 | 88.8 |
30 | 43.5 |
6134 | 70.0 |
174 | 39.6 |
Glycine cleavage system |
M00622 |
0 | 0.0 |
206 | 2.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
206 | 2.3 |
0 | 0.0 |
Nicotinate degradation, nicotinate => fumarate |
M00623 |
0 | 0.0 |
67 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
67 | 0.8 |
0 | 0.0 |
Phthalate degradation, phthalate => protocatechuate |
M00624 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate |
M00625 |
0 | 0.0 |
22 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
22 | 0.3 |
0 | 0.0 |
Methicillin resistance |
M00627 |
0 | 0.0 |
1138 | 12.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1138 | 13.0 |
0 | 0.0 |
beta-Lactam resistance, Bla system |
M00630 |
55 | 5.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
55 | 29.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
D-Galacturonate degradation (fungi), D-galacturonate => glycerol |
M00631 |
0 | 0.0 |
977 | 10.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
977 | 11.1 |
0 | 0.0 |
D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P |
M00632 |
714 | 66.2 |
2925 | 31.8 |
569 | 85.7 |
1 | 0.6 |
144 | 77.0 |
0 | 0.0 |
2916 | 33.3 |
9 | 2.1 |
Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P |
M00633 |
0 | 0.0 |
43 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
43 | 9.8 |
Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P |
M00636 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
Phthalate degradation, phthalate => protocatechuate |
M00637 |
0 | 0.0 |
228 | 2.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
228 | 2.6 |
0 | 0.0 |
Anthranilate degradation, anthranilate => catechol |
M00638 |
0 | 0.0 |
71 | 0.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
71 | 0.8 |
0 | 0.0 |
Salicylate degradation, salicylate => gentisate |
M00639 |
0 | 0.0 |
126 | 1.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
126 | 1.4 |
0 | 0.0 |
Multidrug resistance, efflux pump MexCD-OprJ |
M00641 |
0 | 0.0 |
209 | 2.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
209 | 2.4 |
0 | 0.0 |
Multidrug resistance, efflux pump MexEF-OprN |
M00642 |
0 | 0.0 |
457 | 5.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
457 | 5.2 |
0 | 0.0 |
Multidrug resistance, efflux pump MexJK-OprM |
M00643 |
0 | 0.0 |
110 | 1.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
110 | 1.3 |
0 | 0.0 |
Multidrug resistance, efflux pump MexXY-OprM |
M00649 |
0 | 0.0 |
192 | 2.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
192 | 2.2 |
0 | 0.0 |
Multidrug resistance, efflux pump AdeABC |
M00651 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
9 | 0.1 |
0 | 0.0 |
Vancomycin resistance, D-Ala-D-Lac type |
M00652 |
0 | 0.0 |
32 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
32 | 0.4 |
0 | 0.0 |
Vancomycin resistance, D-Ala-D-Ser type |
M00660 |
0 | 0.0 |
27 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
27 | 0.3 |
0 | 0.0 |
Xanthomonas spp. pathogenicity signature, T3SS and effectors |
M00661 |
8 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 4.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline |
M00664 |
0 | 0.0 |
96 | 1.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
96 | 1.1 |
0 | 0.0 |
Nodulation |
M00672 |
6 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 3.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin |
M00673 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C |
M00674 |
0 | 0.0 |
11 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
11 | 0.1 |
0 | 0.0 |
Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate |
M00675 |
0 | 0.0 |
18 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
18 | 0.2 |
0 | 0.0 |
Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate |
M00696 |
0 | 0.0 |
253 | 2.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
253 | 2.9 |
0 | 0.0 |
Multidrug resistance, efflux pump AcrEF-TolC |
M00697 |
0 | 0.0 |
83 | 0.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
83 | 0.9 |
0 | 0.0 |
Multidrug resistance, efflux pump MdtEF-TolC |
M00698 |
0 | 0.0 |
357 | 3.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
357 | 4.1 |
0 | 0.0 |
Multidrug resistance, efflux pump BpeEF-OprC |
M00700 |
0 | 0.0 |
242 | 2.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
242 | 2.8 |
0 | 0.0 |
Multidrug resistance, efflux pump AbcA |
M00702 |
0 | 0.0 |
110 | 1.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
110 | 1.3 |
0 | 0.0 |
Multidrug resistance, efflux pump NorB |
M00704 |
0 | 0.0 |
68 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
68 | 0.8 |
0 | 0.0 |
Tetracycline resistance, efflux pump Tet38 |
M00705 |
0 | 0.0 |
213 | 2.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
213 | 2.4 |
0 | 0.0 |
Multidrug resistance, efflux pump MepA |
M00714 |
0 | 0.0 |
15 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
15 | 0.2 |
0 | 0.0 |
Multidrug resistance, efflux pump QacA |
M00718 |
0 | 0.0 |
29 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
29 | 0.3 |
0 | 0.0 |
Multidrug resistance, efflux pump MexAB-OprM |
M00725 |
0 | 0.0 |
94 | 1.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
94 | 1.1 |
0 | 0.0 |
Cationic antimicrobial peptide (CAMP) resistance, dltABCD operon |
M00726 |
0 | 0.0 |
103 | 1.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
103 | 1.2 |
0 | 0.0 |
Cationic antimicrobial peptide (CAMP) resistance, lysyl-phosphatidylglycerol (L-PG) synthase MprF |
M00730 |
0 | 0.0 |
77 | 0.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
77 | 0.9 |
0 | 0.0 |
Cationic antimicrobial peptide (CAMP) resistance, VraFG transporter |
M00736 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A |
M00740 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 1.8 |
Methylaspartate cycle |
M00741 |
473 | 43.8 |
1520 | 16.5 |
453 | 68.2 |
3 | 1.9 |
1 | 0.5 |
16 | 23.2 |
1378 | 15.7 |
142 | 32.3 |
Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA |
M00744 |
0 | 0.0 |
55 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
55 | 0.6 |
0 | 0.0 |
Cationic antimicrobial peptide (CAMP) resistance, protease PgtE |
M00745 |
0 | 0.0 |
226 | 2.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
226 | 2.6 |
0 | 0.0 |
Imipenem resistance, repression of porin OprD |
M00746 |
0 | 0.0 |
43 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
43 | 0.5 |
0 | 0.0 |
Multidrug resistance, repression of porin OmpF |
M00761 |
0 | 0.0 |
593 | 6.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
593 | 6.8 |
0 | 0.0 |
Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N |
M00763 |
0 | 0.0 |
165 | 1.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
165 | 37.6 |
Ornithine biosynthesis, mediated by LysW, glutamate => ornithine |
M00769 |
0 | 0.0 |
20 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
20 | 0.2 |
0 | 0.0 |
Multidrug resistance, efflux pump MexPQ-OpmE |
M00773 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin |
M00774 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B |
M00775 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin |
M00776 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Pikromycin/methymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin |
M00777 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b |
M00778 |
0 | 0.0 |
124 | 1.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
124 | 1.4 |
0 | 0.0 |
Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide |
M00779 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin |
M00780 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline |
M00781 |
0 | 0.0 |
12 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
12 | 0.1 |
0 | 0.0 |
Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone |
M00782 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin |
M00783 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C |
M00784 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A |
M00785 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cycloserine biosynthesis, arginine/serine => cycloserine |
M00786 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A |
M00787 |
0 | 0.0 |
62 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
62 | 0.7 |
0 | 0.0 |
Bacilysin biosynthesis, prephenate => bacilysin |
M00788 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Terpentecin biosynthesis, GGAP => terpentecin |
M00789 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Rebeccamycin biosynthesis, tryptophan => rebeccamycin |
M00790 |
0 | 0.0 |
50 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
50 | 0.6 |
0 | 0.0 |
Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin |
M00793 |
0 | 0.0 |
5438 | 59.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5250 | 59.9 |
188 | 42.8 |
dTDP-L-rhamnose biosynthesis |
M00794 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
dTDP-6-deoxy-D-allose biosynthesis |
M00795 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
dTDP-beta-L-noviose biosynthesis |
M00796 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
dTDP-D-mycaminose biosynthesis |
M00797 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
dTDP-D-desosamine biosynthesis |
M00798 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
dTDP-L-mycarose biosynthesis |
M00799 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
dTDP-L-oleandrose biosynthesis |
M00800 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
dTDP-L-megosamine biosynthesis |
M00801 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
dTDP-L-olivose biosynthesis |
M00802 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
dTDP-D-forosamine biosynthesis |
M00803 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
dTDP-D-angolosamine biosynthesis |
M00804 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Complete nitrification, comammox, ammonia => nitrite => nitrate |
M00805 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Staurosporine biosynthesis, tryptophan => staurosporine |
M00808 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
14 | 0.2 |
0 | 0.0 |
Violacein biosynthesis, tryptophan => violacein |
M00810 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde |
M00811 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde |
M00814 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose |
M00815 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A |
M00819 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone |
M00823 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Chlortetracycline biosynthesis, pretetramide => chlortetracycline |
M00824 |
0 | 0.0 |
44 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
44 | 0.5 |
0 | 0.0 |
9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core |
M00825 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core |
M00826 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA |
M00827 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
C-1027 beta-amino acid moiety biosynthesis, tyrosine => 3-chloro-4,5-dihydroxy-beta-phenylalanyl-PCP |
M00828 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
Maduropeptin beta-hydroxy acid moiety biosynthesis, tyrosine => 3-(4-hydroxyphenyl)-3-oxopropanoyl-PCP |
M00829 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA |
M00830 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 0.0 |
0 | 0.0 |
Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA |
M00831 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA |
M00832 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Kedarcidin 2-aza-3-chloro-beta-tyrosine moiety biosynthesis, azatyrosine => 2-aza-3-chloro-beta-tyrosyl-PCP |
M00833 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Calicheamicin biosynthesis, calicheamicinone => calicheamicin |
M00834 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Calicheamicin orsellinate moiety biosynthesis, malonyl-CoA => orsellinate-ACP => 5-iodo-2,3-dimethoxyorsellinate-ACP |
M00835 |
0 | 0.0 |
23 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
23 | 0.3 |
0 | 0.0 |
Pyocyanine biosynthesis, chorismate => pyocyanine |
M00836 |
0 | 0.0 |
45 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
45 | 10.3 |
Coenzyme F430 biosynthesis, sirohydrochlorin => coenzyme F430 |
M00837 |
0 | 0.0 |
21 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
21 | 0.2 |
0 | 0.0 |
Prodigiosin biosynthesis, L-proline => prodigiosin |
M00838 |
0 | 0.0 |
13 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
13 | 0.1 |
0 | 0.0 |
Undecylprodigiosin biosynthesis, L-proline => undecylprodigiosin |
M00840 |
0 | 0.0 |
83 | 0.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
83 | 0.9 |
0 | 0.0 |
Tetrahydrofolate biosynthesis, mediated by ribA and trpF, GTP => THF |
M00841 |
18 | 1.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
18 | 26.1 |
0 | 0.0 |
0 | 0.0 |
Tetrahydrofolate biosynthesis, mediated by PTPS, GTP => THF |
M00842 |
617 | 57.2 |
0 | 0.0 |
613 | 92.3 |
0 | 0.0 |
0 | 0.0 |
4 | 5.8 |
0 | 0.0 |
0 | 0.0 |
Tetrahydrobiopterin biosynthesis, GTP => BH4 |
M00843 |
0 | 0.0 |
17 | 0.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
17 | 0.2 |
0 | 0.0 |
L-threo-Tetrahydrobiopterin biosynthesis, GTP => L-threo-BH4 |
M00844 |
748 | 69.3 |
6844 | 74.3 |
417 | 62.8 |
155 | 97.5 |
170 | 90.9 |
6 | 8.7 |
6485 | 74.0 |
359 | 81.8 |
Arginine biosynthesis, ornithine => arginine |
M00845 |
0 | 0.0 |
143 | 1.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
143 | 1.6 |
0 | 0.0 |
Arginine biosynthesis, glutamate => acetylcitrulline => arginine |
M00846 |
0 | 0.0 |
2660 | 28.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2658 | 30.3 |
2 | 0.5 |
Siroheme biosynthesis, glutamyl-tRNA => siroheme |
M00847 |
0 | 0.0 |
282 | 3.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
169 | 1.9 |
113 | 25.7 |
Heme biosynthesis, archaea, siroheme => heme |
M00848 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Aurachin biosynthesis, anthranilate => aurachin A |
M00849 |
0 | 0.0 |
355 | 3.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
355 | 80.9 |
C5 isoprenoid biosynthesis, mevalonate pathway, archaea |
M00850 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
Vibrio cholerae pathogenicity signature, cholera toxins |
M00851 |
0 | 0.0 |
144 | 1.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
144 | 1.6 |
0 | 0.0 |
Carbapenem resistance |
M00852 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
10 | 0.1 |
0 | 0.0 |
Vibrio cholerae pathogenicity signature, toxin coregulated pilus |
M00853 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
ETEC pathogenicity signature, colonization factors |
M00854 |
837 | 77.6 |
3898 | 42.3 |
527 | 79.4 |
156 | 98.1 |
152 | 81.3 |
2 | 2.9 |
3881 | 44.3 |
17 | 3.9 |
Glycogen biosynthesis, glucose-1P => glycogen/starch |
M00855 |
818 | 75.8 |
1417 | 15.4 |
643 | 96.8 |
0 | 0.0 |
163 | 87.2 |
12 | 17.4 |
1416 | 16.2 |
1 | 0.2 |
Glycogen degradation, glycogen => glucose-6P |
M00856 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
6 | 0.1 |
0 | 0.0 |
Salmonella enterica pathogenicity signature, typhoid toxin |
M00857 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
Salmonella enterica pathogenicity signature, Vi antigen |
M00859 |
0 | 0.0 |
12 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
12 | 0.1 |
0 | 0.0 |
Bacillus anthracis pathogenicity signature, anthrax toxin |
M00860 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
7 | 0.1 |
0 | 0.0 |
Bacillus anthracis pathogenicity signature, polyglutamic acid capsule biosynthesis |
M00861 |
614 | 56.9 |
0 | 0.0 |
611 | 92.0 |
0 | 0.0 |
0 | 0.0 |
3 | 4.3 |
0 | 0.0 |
0 | 0.0 |
beta-Oxidation, peroxisome, VLCFA |
M00862 |
258 | 23.9 |
0 | 0.0 |
258 | 38.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
beta-Oxidation, peroxisome, tri/dihydroxycholestanoyl-CoA => choloyl/chenodeoxycholoyl-CoA |
M00866 |
0 | 0.0 |
68 | 0.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
68 | 0.8 |
0 | 0.0 |
KDO2-lipid A biosynthesis, Raetz pathway, non-LpxL-LpxM type |
M00867 |
0 | 0.0 |
59 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
59 | 0.7 |
0 | 0.0 |
KDO2-lipid A modification pathway |
M00868 |
632 | 58.6 |
13 | 0.1 |
488 | 73.5 |
0 | 0.0 |
144 | 77.0 |
0 | 0.0 |
13 | 0.1 |
0 | 0.0 |
Heme biosynthesis, animals and fungi, glycine => heme |
M00872 |
341 | 31.6 |
0 | 0.0 |
340 | 51.2 |
0 | 0.0 |
0 | 0.0 |
1 | 1.4 |
0 | 0.0 |
0 | 0.0 |
O-glycan biosynthesis, mannose type (core M3) |
M00873 |
242 | 22.4 |
0 | 0.0 |
242 | 36.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fatty acid biosynthesis in mitochondria, animals |
M00874 |
36 | 3.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
36 | 19.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fatty acid biosynthesis in mitochondria, fungi |
M00875 |
0 | 0.0 |
74 | 0.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
74 | 0.8 |
0 | 0.0 |
Staphyloferrin B biosynthesis, L-serine => staphyloferrin B |
M00876 |
0 | 0.0 |
111 | 1.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
111 | 1.3 |
0 | 0.0 |
Staphyloferrin A biosynthesis, L-ornithine => staphyloferrin A |
M00877 |
0 | 0.0 |
72 | 0.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
72 | 0.8 |
0 | 0.0 |
Kanosamine biosynthesis, glucose 6-phosphate => kanosamine |
M00878 |
0 | 0.0 |
195 | 2.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
195 | 2.2 |
0 | 0.0 |
Phenylacetate degradation, phenylaxetate => acetyl-CoA/succinyl-CoA |
M00879 |
0 | 0.0 |
932 | 10.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
932 | 10.6 |
0 | 0.0 |
Arginine succinyltransferase pathway, arginine => glutamate |
M00880 |
716 | 66.4 |
4378 | 47.6 |
560 | 84.3 |
140 | 88.1 |
16 | 8.6 |
0 | 0.0 |
4019 | 45.8 |
359 | 81.8 |
Molybdenum cofactor biosynthesis, GTP => molybdenum cofactor |
M00881 |
173 | 16.0 |
6037 | 65.6 |
0 | 0.0 |
151 | 95.0 |
0 | 0.0 |
22 | 31.9 |
6026 | 68.7 |
11 | 2.5 |
Lipoic acid biosynthesis, plants and bacteria, octanoyl-ACP => dihydrolipoyl-E2/H |
M00882 |
877 | 81.3 |
0 | 0.0 |
558 | 84.0 |
150 | 94.3 |
167 | 89.3 |
2 | 2.9 |
0 | 0.0 |
0 | 0.0 |
Lipoic acid biosynthesis, eukaryotes, octanoyl-ACP => dihydrolipoyl-H |
M00883 |
538 | 49.9 |
512 | 5.6 |
538 | 81.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
512 | 5.8 |
0 | 0.0 |
Lipoic acid biosynthesis, animals and bacteria, octanoyl-ACP => dihydrolipoyl-H => dihydrolipoyl-E2 |
M00884 |
40 | 3.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
40 | 21.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Lipoic acid biosynthesis, octanoyl-CoA => dihydrolipoyl-E2 |
M00885 |
0 | 0.0 |
161 | 1.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
161 | 1.8 |
0 | 0.0 |
Meromycolic acid biosynthesis, initiation and elongation FAS II (KasA) |
M00886 |
0 | 0.0 |
81 | 0.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
81 | 0.9 |
0 | 0.0 |
Meromycolic acid biosynthesis, initiation and elongation FAS II (KasA and KasB) |
M00887 |
0 | 0.0 |
368 | 4.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
368 | 4.2 |
0 | 0.0 |
Mycolic acid biosynthesis, meromycolic acid + alpha-carboxyacyl-CoA + trehalose => TMM => TDM/mAGP/GMM |
M00888 |
0 | 0.0 |
486 | 5.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
486 | 5.5 |
0 | 0.0 |
Galactofuranan biosynthesis, decaprenyl phosphate + UDP-GlcNAc (+ dTDP-Rha/UDP-Galf) => GL-5 |
M00889 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
0 | 0.0 |
Puromycin biosynthesis, ATP => puromycin |
M00890 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Roseoflavin biosynthesis, FMN => roseoflavin |
M00891 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ditryptophenaline biosynthesis, tryptophan + phenylalanine => ditryptophenaline |
M00892 |
983 | 91.1 |
0 | 0.0 |
647 | 97.4 |
149 | 93.7 |
170 | 90.9 |
17 | 24.6 |
0 | 0.0 |
0 | 0.0 |
UDP-N-acetyl-D-glucosamine biosynthesis, eukaryotes, glucose => UDP-GlcNAc |
M00893 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Lovastatin biosynthesis, malonyl-CoA => lovastatin acid |
M00894 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cannabidiol biosynthesis, malonyl-CoA => cannabidiol/dronabinol |
M00895 |
0 | 0.0 |
82 | 0.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
82 | 0.9 |
0 | 0.0 |
Thiamine biosynthesis, prokaryotes, AIR (+ DXP/glycine) => TMP/TPP |
M00896 |
0 | 0.0 |
353 | 3.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
63 | 0.7 |
290 | 66.1 |
Thiamine biosynthesis, archaea, AIR (+ NAD+) => TMP/TPP |
M00897 |
123 | 11.4 |
0 | 0.0 |
0 | 0.0 |
123 | 77.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Thiamine biosynthesis, plants, AIR (+ NAD+) => TMP/thiamine/TPP |
M00898 |
89 | 8.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
89 | 47.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Thiamine biosynthesis, pyridoxal-5P => TMP/thiamine/TPP |
M00899 |
148 | 13.7 |
2945 | 32.0 |
0 | 0.0 |
147 | 92.5 |
0 | 0.0 |
1 | 1.4 |
2793 | 31.9 |
152 | 34.6 |
Thiamine salvage pathway, HMP/HET => TMP |
M00900 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Crocin biosynthesis, crocetin => crocin |
M00901 |
3 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
3 | 1.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fumiquinazoline biosynthesis, tryptophan + alanine + anthranilate => fumiquinazoline |
M00902 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Podophyllotoxin biosynthesis, coniferyl alcohol => podophyllotoxin |
M00903 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fosfomycin biosynthesis, phosphoenolpyruvate => fosfomycin |
M00904 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
4 | 0.0 |
0 | 0.0 |
Dapdiamides biosynthesis, L-2,3-diaminopropanoate => dapdiamide A/B/C |
M00905 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5 | 0.1 |
0 | 0.0 |
Grixazone biosynthesis, aspartate 4-semialdehyde => grixazone B |
M00906 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Ethynylserine biosynthesis, lysine => ethynylserine |
M00909 |
0 | 0.0 |
5696 | 61.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
5696 | 65.0 |
0 | 0.0 |
UDP-N-acetyl-D-glucosamine biosynthesis, prokaryotes, glucose => UDP-GlcNAc |
M00910 |
155 | 14.4 |
0 | 0.0 |
0 | 0.0 |
154 | 96.9 |
0 | 0.0 |
1 | 1.4 |
0 | 0.0 |
0 | 0.0 |
Phenylalanine biosynthesis, chorismate => arogenate => phenylalanine |
M00911 |
38 | 3.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
38 | 20.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Riboflavin biosynthesis, fungi, GTP => riboflavin/FMN/FAD |
M00912 |
398 | 36.9 |
68 | 0.7 |
331 | 49.8 |
0 | 0.0 |
66 | 35.3 |
1 | 1.4 |
68 | 0.8 |
0 | 0.0 |
NAD biosynthesis, tryptophan => quinolinate => NAD |
M00913 |
47 | 4.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
47 | 25.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Pantothenate biosynthesis, 2-oxoisovalerate/spermine => pantothenate |
M00914 |
0 | 0.0 |
152 | 1.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
152 | 34.6 |
Coenzyme A biosynthesis, archaea, 2-oxoisovalerate => 4-phosphopantoate => CoA |
M00915 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Caffeine degradation, caffeine => xanthine |
M00916 |
381 | 35.3 |
2874 | 31.2 |
35 | 5.3 |
156 | 98.1 |
161 | 86.1 |
29 | 42.0 |
2496 | 28.5 |
378 | 86.1 |
Pyridoxal-P biosynthesis, R5P + glyceraldehyde-3P + glutamine => pyridoxal-P |
M00917 |
136 | 12.6 |
0 | 0.0 |
0 | 0.0 |
136 | 85.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Phytosterol biosynthesis, squalene 2,3-epoxide => campesterol/sitosterol |
M00918 |
0 | 0.0 |
202 | 2.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
202 | 2.3 |
0 | 0.0 |
Aerobactin biosynthesis, lysine => aerobactin |
M00919 |
0 | 0.0 |
342 | 3.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
342 | 3.9 |
0 | 0.0 |
Ectoine degradation, ectoine => aspartate |
M00921 |
0 | 0.0 |
11 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
11 | 0.1 |
0 | 0.0 |
Cyclooctatin biosynthesis, dimethylallyl-PP + isopentenyl-PP => cyclooctatin |
M00922 |
0 | 0.0 |
90 | 1.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
90 | 1.0 |
0 | 0.0 |
CMP-Neu5Ac biosynthesis |
M00923 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
UDP-L-FucNAm biosynthesis |
M00924 |
0 | 0.0 |
680 | 7.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
626 | 7.1 |
54 | 12.3 |
Cobalamin biosynthesis, anaerobic, uroporphyrinogen III => sirohydrochlorin => cobyrinate a,c-diamide |
M00925 |
0 | 0.0 |
288 | 3.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
288 | 3.3 |
0 | 0.0 |
Cobalamin biosynthesis, aerobic, uroporphyrinogen III => precorrin 2 => cobyrinate a,c-diamide |
M00926 |
0 | 0.0 |
1545 | 16.8 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1545 | 17.6 |
0 | 0.0 |
Heme biosynthesis, bacteria, glutamyl-tRNA => coproporphyrin III => heme |
M00927 |
136 | 12.6 |
0 | 0.0 |
0 | 0.0 |
136 | 85.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Gibberellin A12 biosynthesis, GAPP => GA12 |
M00928 |
144 | 13.3 |
0 | 0.0 |
0 | 0.0 |
144 | 90.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Gibberellin A4/A1 biosynthesis, GA12/GA53 => GA4/GA1 |
M00929 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Gibberellin A1 biosynthesis, GGPP => GA1 |
M00930 |
0 | 0.0 |
476 | 5.2 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
476 | 5.4 |
0 | 0.0 |
Menaquinone biosynthesis, futalosine pathway |
M00931 |
0 | 0.0 |
225 | 2.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
225 | 2.6 |
0 | 0.0 |
Menaquinone biosynthesis, modified futalosine pathway |
M00932 |
136 | 12.6 |
71 | 0.8 |
0 | 0.0 |
136 | 85.5 |
0 | 0.0 |
0 | 0.0 |
71 | 0.8 |
0 | 0.0 |
Phylloquinone biosynthesis, chorismate (+ phytyl-PP) => phylloquinol |
M00933 |
151 | 14.0 |
0 | 0.0 |
0 | 0.0 |
149 | 93.7 |
0 | 0.0 |
2 | 2.9 |
0 | 0.0 |
0 | 0.0 |
Plastoquinone biosynthesis, homogentisate + solanesyl-PP => plastoquinol |
M00934 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Mycinamicin biosynthesis, malonyl-CoA + methylmalonyl-CoA => protomycinolide IV => mycinamicin II |
M00935 |
0 | 0.0 |
43 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
43 | 9.8 |
Methanofuran biosynthesis |
M00936 |
66 | 6.1 |
0 | 0.0 |
0 | 0.0 |
66 | 41.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Melatonin biosynthesis, plants, tryptophan => serotonin => melatonin |
M00937 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Aflatoxin biosynthesis, malonyl-CoA => aflatoxin B1 |
M00938 |
919 | 85.2 |
4721 | 51.3 |
572 | 86.1 |
156 | 98.1 |
141 | 75.4 |
50 | 72.5 |
4649 | 53.0 |
72 | 16.4 |
Pyrimidine deoxyribonucleotide biosynthesis, UDP => dTTP |
M00939 |
0 | 0.0 |
325 | 3.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
325 | 3.7 |
0 | 0.0 |
Pyrimidine degradation, uracil => 3-hydroxypropanoate |
M00940 |
44 | 4.1 |
0 | 0.0 |
0 | 0.0 |
44 | 27.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Flavanone biosynthesis, p-coumaroyl-CoA => liquiritigenin |
M00941 |
18 | 1.7 |
0 | 0.0 |
0 | 0.0 |
18 | 11.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Isoflavone biosynthesis, liquiritigenin/naringenin => daidzein/genistein |
M00942 |
17 | 1.6 |
0 | 0.0 |
0 | 0.0 |
17 | 10.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Pterocarpan biosynthesis, daidzein => medicarpin |
M00943 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Reticuline biosynthesis, dopamine + 4HPAA => (S)-reticuline |
M00944 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Morphine biosynthesis, (S)-reticuline => morphine |
M00945 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Sanguinarine biosynthesis, (S)-reticuline => sanguinarine |
M00946 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Noscapine biosynthesis, (S)-reticuline => noscapine |
M00947 |
0 | 0.0 |
120 | 1.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
120 | 1.4 |
0 | 0.0 |
D-Arginine racemization, D-arginine => L-arginine |
M00948 |
0 | 0.0 |
543 | 5.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
543 | 6.2 |
0 | 0.0 |
Hydroxyproline degradation, trans-4-hydroxy-L-proline => 2-oxoglutarate |
M00949 |
0 | 0.0 |
122 | 1.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
122 | 1.4 |
0 | 0.0 |
Staphylopine biosynthesis, L-histidine => staphylopine |
M00950 |
0 | 0.0 |
157 | 1.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
118 | 1.3 |
39 | 8.9 |
Biotin biosynthesis, BioU pathway, pimeloyl-ACP/CoA => biotin |
M00951 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Cremeomycin biosynthesis, aspartate/3,4-AHBA => cremeomycin |
M00952 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Benzoxazinoid biosynthesis, indoleglycerol phosphate => DIMBOA-glucoside |
M00953 |
16 | 1.5 |
0 | 0.0 |
0 | 0.0 |
16 | 10.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Mugineic acid biosynthesis, methionine => 3-epihydroxymugineic acid |
M00956 |
0 | 0.0 |
184 | 2.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
184 | 2.1 |
0 | 0.0 |
Lysine degradation, bacteria, L-lysine => succinate |
M00957 |
0 | 0.0 |
173 | 1.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
173 | 2.0 |
0 | 0.0 |
Lysine degradation, bacteria, L-lysine => glutarate => succinate/acetyl-CoA |
M00958 |
665 | 61.6 |
2367 | 25.7 |
616 | 92.8 |
0 | 0.0 |
40 | 21.4 |
9 | 13.0 |
2367 | 27.0 |
0 | 0.0 |
Adenine ribonucleotide degradation, AMP => Urate |
M00959 |
612 | 56.7 |
1893 | 20.6 |
592 | 89.2 |
0 | 0.0 |
16 | 8.6 |
4 | 5.8 |
1893 | 21.6 |
0 | 0.0 |
Guanine ribonucleotide degradation, GMP => Urate |
M00960 |
0 | 0.0 |
27 | 0.3 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
27 | 0.3 |
0 | 0.0 |
Lysine degradation, bacteria, L-lysine => D-lysine => succinate |
M00961 |
4 | 0.4 |
0 | 0.0 |
0 | 0.0 |
4 | 2.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Betacyanin biosynthesis, L-tyrosine => amaranthin |
M00962 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Psilocybin biosynthesis, tryptophan => psilocybin |
M00963 |
7 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
7 | 3.7 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Chanoclavine aldehyde biosynthesis, tryptophan => chanoclavine-I aldehyde |
M00964 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fumigaclavine biosynthesis, chanoclavine-I aldehyde => fumigaclavine C |
M00965 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Vinblastine biosynthesis, geissoschizine => vinblastine |
M00966 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Equol biosynthesis, daidzein => equol |
M00967 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
8 | 0.1 |
0 | 0.0 |
Flavone degradation, luteolin/apigenin => DHCA/phloretate |
M00968 |
0 | 0.0 |
221 | 2.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.0 |
220 | 50.1 |
Pentose bisphosphate pathway (nucleoside degradation), archaea, nucleoside/NMP => 3-PGA/glycerone phosphate |
M00969 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
1 | 0.5 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Fumagillin biosynthesis, farnesyl-PP => fumagillin |
M00970 |
920 | 85.3 |
5882 | 63.9 |
625 | 94.1 |
154 | 96.9 |
107 | 57.2 |
34 | 49.3 |
5859 | 66.8 |
23 | 5.2 |
Proline degradation, proline => glutamate |
M00971 |
1 | 0.1 |
0 | 0.0 |
0 | 0.0 |
1 | 0.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
QS-7 biosynthesis, 2,3-epoxysqualene => QS-7 |
M00972 |
913 | 84.6 |
1524 | 16.6 |
640 | 96.4 |
152 | 95.6 |
104 | 55.6 |
17 | 24.6 |
1524 | 17.4 |
0 | 0.0 |
Proline metabolism |
M00973 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
2 | 0.0 |
0 | 0.0 |
Anammox, nitrite + ammonia => nitrogen |
M00974 |
434 | 40.2 |
0 | 0.0 |
434 | 65.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Betaine metabolism, animals, betaine => glycine |
M00975 |
0 | 0.0 |
633 | 6.9 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
633 | 7.2 |
0 | 0.0 |
Betaine degradation, bacteria, betaine => pyruvate |
M00976 |
408 | 37.8 |
0 | 0.0 |
408 | 61.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C19-Steroid hormone biosynthesis, pregnenolone => testosterone => dihydrotestosterone |
M00977 |
162 | 15.0 |
0 | 0.0 |
162 | 24.4 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
C19-Steroid hormone biosynthesis (androgen backdoor pathway), pregnenolone => androsterone => dihydrotestosterone |
M00978 |
0 | 0.0 |
881 | 9.6 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
879 | 10.0 |
2 | 0.5 |
Ornithine-ammonia cycle |
M00979 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Ajmaline biosynthesis, geissoschizine => ajmaline |
M00980 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Strychnine biosynthesis, geissoschizine => strychnine |
M00981 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
0 | 0.0 |
Geissoschizine biosynthesis, tryptophan => geissoschizine |